For example, we could transplant human liver organoids into immunodeficient animals and induce liver fibrosis with CCL4 or other toxins to establish in vivo human liver fibrosis models for drug tests (Benten et al. 2018; Ma et al. 2022; Wang et al. 2022). The gene discussed is CCL4; the disease is Hepatic fibrosis.